Drug Discovery of DKK1 Inhibitors

Dickkopf-1 (DKK1) is a well-characterized Wnt inhibitor and component of the Wnt/β-catenin signaling pathway, whose dysregulation is associated with multiple abnormal pathologies including osteoporosis, Alzheimer’s disease, diabetes, and various cancers. The Wnt signaling pathway has fundamental rol...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Hewen, Zhang, Zongkang, Yu, Yuanyuan, Chu, Hang Yin, Yu, Sifan, Yao, Shanshan, Zhang, Ge, Zhang, Bao-Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959454/
https://www.ncbi.nlm.nih.gov/pubmed/35355709
http://dx.doi.org/10.3389/fphar.2022.847387

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8959454/
https://www.ncbi.nlm.nih.gov/pubmed/35355709
http://dx.doi.org/10.3389/fphar.2022.847387

Ejemplares similares